Deal Watch: Six Firms Advise on J&J's Actelion Acquisition

, The Am Law Daily


Cravath, Swaine & Moore, Slaughter and May and Wachtell, Lipton, Rosen & Katz are leading a team of firms that have landed lead roles on Johnson & Johnson’s proposed $30 billion buy of Swiss biotechnology company Actelion.

This premium content is reserved for American Lawyer subscribers.

Continue reading by getting started with a subscription.

Already a subscriber? Log in now

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article #1202777923034

Thank you!

This article's comments will be reviewed.